Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bintrafusp Alfa in Stage II-III HER2+ Breast Cancer
NCT03620201Phase 1Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2018
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial of bintrafusp alfa in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2018; status: completed.
02
Drugs
bintrafusp alfa
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03620201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03620201.